Gastroenterology
2 drugs are in development for Celiac Disease.
- Companies
- 2
- Clinical trials
- 12
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Celiac Disease pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| fb102 | Forte Biosciences, Inc. (FBRX) |
Early Phase 1(1)
| Drug | Company |
|---|---|
| VTP-1000 | Barinthus Biotherapeutics plc. (BRNS) |
About this indication
Celiac Disease context
Gastroenterology·MeSH: Celiac Disease (D002446)
Also known as: Enteropathies, Gluten, Enteropathies, Gluten-Sensitive, Enteropathy, Gluten, Enteropathy, Gluten-Sensitive, Nontropical Sprue, Sprue, Sprue, Celiac
Frequently asked questions
How many drugs are in development for Celiac Disease?
BioSniper tracks 2 drugs in development for Celiac Disease across 2 companies.
How many clinical trials target Celiac Disease?
There are 12 clinical trials targeting Celiac Disease tracked by BioSniper.